Early Intermittent Intensive Insulin Therapy as an Effective Treatment of Type 2 Diabetes (RESET-IT Main Trial)

NCT02192424 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

109

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Metformin alone
DRUG: Metformin + Intermittent Insulin Therapy

Sponsor

Mount Sinai Hospital, Canada

Collaborators

[object Object]